CA1176981A - Method for preventing body fat deposition in mammals - Google Patents

Method for preventing body fat deposition in mammals

Info

Publication number
CA1176981A
CA1176981A CA000399954A CA399954A CA1176981A CA 1176981 A CA1176981 A CA 1176981A CA 000399954 A CA000399954 A CA 000399954A CA 399954 A CA399954 A CA 399954A CA 1176981 A CA1176981 A CA 1176981A
Authority
CA
Canada
Prior art keywords
mixture
pyruvate
dihydroxyacetone
mammal
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000399954A
Other languages
English (en)
French (fr)
Inventor
Ronald T. Stanko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Montefiore Hospital Association of Western Pennsylvania
Original Assignee
Montefiore Hospital Association of Western Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/249,812 external-priority patent/US4351835A/en
Application filed by Montefiore Hospital Association of Western Pennsylvania filed Critical Montefiore Hospital Association of Western Pennsylvania
Application granted granted Critical
Publication of CA1176981A publication Critical patent/CA1176981A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000399954A 1981-04-01 1982-03-31 Method for preventing body fat deposition in mammals Expired CA1176981A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/249,812 US4351835A (en) 1981-04-01 1981-04-01 Method for preventing body fat deposition in mammals
US249,812 1981-04-01
US06/346,181 US4415576A (en) 1981-04-01 1982-02-09 Method for preventing body fat deposition in mammals
US346,181 1989-04-28

Publications (1)

Publication Number Publication Date
CA1176981A true CA1176981A (en) 1984-10-30

Family

ID=26940368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000399954A Expired CA1176981A (en) 1981-04-01 1982-03-31 Method for preventing body fat deposition in mammals

Country Status (8)

Country Link
US (1) US4415576A (fi)
CA (1) CA1176981A (fi)
CH (1) CH653891A5 (fi)
DE (1) DE3211587A1 (fi)
FI (1) FI821119L (fi)
GB (1) GB2095555B (fi)
PT (1) PT74686A (fi)
SE (1) SE464796B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5403921A (en) * 1993-04-30 1995-04-04 University Of New Mexico Exercise hydration regimen to enhance exercise endurance and performance
US5612374A (en) * 1994-02-14 1997-03-18 Ronald T. Stanko Inhibiting growth of mammary adenocarcinoma
US5480909A (en) * 1994-08-08 1996-01-02 University Of Pittsburgh Medical Center Method for inhibiting generation of free-radicals
US5801198A (en) * 1995-07-13 1998-09-01 University Of Pittsburgh Medical Center Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
CA2205112C (en) * 1995-09-19 2008-11-18 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US5886040A (en) * 1997-06-17 1999-03-23 Amt Labs, Inc. Creatine pyruvate salt with enhanced palatability
DE19729786A1 (de) * 1997-07-11 1999-01-14 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von Calciumpyruvaten
US6177576B1 (en) 1997-08-05 2001-01-23 Michael J. Arnold Pyruvate saccaride ketals
US5876763A (en) * 1998-05-26 1999-03-02 University Of New Mexico Glycerol enhanced rehydration formulation
DE19836450A1 (de) * 1998-08-12 2000-02-17 Sueddeutsche Kalkstickstoff Stabile, Brenztraubensäure (Salze) enthaltende Formulierung für die Tierernährung
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
DE60301878T2 (de) * 2002-04-17 2006-08-10 Critical Therapeutics, Inc., Lexington Pharmazeutische zusammensetzung enthaltend ein alpha-ketoalkansäureester oder -amid und milchsäure oder ein milchsäuresalz
CN101472613A (zh) 2006-04-12 2009-07-01 R·L·亚历山大 包含丙酮酸烷基酯的组合物及其应用
US20200237815A1 (en) 2017-02-24 2020-07-30 Alain Martin Methods for treatment of lung damage and for inhibition of lung fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals

Also Published As

Publication number Publication date
SE8202064L (sv) 1982-10-02
GB2095555B (en) 1985-10-16
PT74686A (en) 1982-05-01
FI821119A0 (fi) 1982-03-31
US4415576A (en) 1983-11-15
CH653891A5 (de) 1986-01-31
SE464796B (sv) 1991-06-17
FI821119L (fi) 1982-10-02
DE3211587A1 (de) 1982-10-28
GB2095555A (en) 1982-10-06

Similar Documents

Publication Publication Date Title
CA1176981A (en) Method for preventing body fat deposition in mammals
US4351835A (en) Method for preventing body fat deposition in mammals
US4645764A (en) Method for preventing body fat deposition in animals
US5929066A (en) Chromium/biotin treatment of Type II diabetes
US4812479A (en) Method for preventing body fat deposition in mammals
US4446138A (en) Method and composition for reducing weight
EP0007691B1 (en) Compositions for use in decreasing appetite for calories as carbohydrates
US4158057A (en) Prevention of the accumulation of fatty deposits in the liver
AU751431B2 (en) Chromium/biotin treatment of type II diabetes
EP0825861A1 (en) High-dose chromic tripicolinate for the treatment of type ii diabetes
JPS58134031A (ja) 多発性硬化症処置におけるジヒドロシクロスポリンｄ
US5422125A (en) Method and composition for treatment of insulin resistance syndromes
LONGCOPE et al. The use of BAL (British anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury and other metallic poisons
US4594249A (en) Method of altering intoxicating effects of alcohol
KRALL et al. Clinical evaluation of formamidinyliminourea, a new biguanide oral blood sugar lowering compound: comparison with other hypoglycemic agents
US4501738A (en) Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
RICHTER et al. Calcium appetite of parathyroidectomized rats used to bioassay substances which affect blood calcium
KR20070086007A (ko) 당뇨병의 치료를 위한 의약 조성물
US3932659A (en) Biologically active substance
Kratz et al. Long term effects of quinine on food intake and body weight in the rat
US4122188A (en) Treatment of hyperlipoproteinemia with a dichloroacetate salt
US5948824A (en) Use of a chemical agent for reducing the changes in waistline and the effect of constipation due to the taking of other agents
NZ200088A (en) Control of weight gain in non-human mammals with pyruvate and dihydroxyacetone
AU2002302012B2 (en) Chromim/biotin treatment of type II diabetes
AU704714B2 (en) Composition for treatment of insulin resistance syndromes

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry